-
1
-
-
0028802726
-
Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
-
BEAVO, J. A., 1995, Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiological Reviews, 75, 725-748.
-
(1995)
Physiological Reviews
, vol.75
, pp. 725-748
-
-
Beavo, J.A.1
-
2
-
-
0018606615
-
Noncompartmental determination of the steady-state volume of distribution
-
BENET, L. Z. and GALEAZZI, R. L., 1971, Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Sciences, 68, 1071-1074.
-
(1971)
Journal of Pharmaceutical Sciences
, vol.68
, pp. 1071-1074
-
-
Benet, L.Z.1
Galeazzi, R.L.2
-
3
-
-
0030806348
-
Physiological parameter values for physiologically based pharmacokinetic models
-
BROWN, R. P., DELP, M. D., LINDSTEDT, S. L., RHOMBERG, L. R. and BELILES, R. P., 1997, Physiological parameter values for physiologically based pharmacokinetic models. Toxicological Industrial Health, 13, 407-484.
-
(1997)
Toxicological Industrial Health
, vol.13
, pp. 407-484
-
-
Brown, R.P.1
Delp, M.D.2
Lindstedt, S.L.3
Rhomberg, L.R.4
Beliles, R.P.5
-
4
-
-
0035963952
-
Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: A randomised, dose-ranging study
-
COMPTON, C. H., GUBB, J., NIEMAN, R., EDELSON, J., AMIT, O., BAKST, A., AYRES, J. G., CREEMERS, J. P., SCHULTZE-WERNINGHAUS, G., BRAMBILLA, C. and BARNES, N. C., 2001, Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet, 358, 265-270.
-
(2001)
Lancet
, vol.358
, pp. 265-270
-
-
Compton, C.H.1
Gubb, J.2
Nieman, R.3
Edelson, J.4
Amit, O.5
Bakst, A.6
Ayres, J.G.7
Creemers, J.P.8
Schultze-Werninghaus, G.9
Brambilla, C.10
Barnes, N.C.11
-
5
-
-
0032793959
-
OATP and p-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
-
CVETKOVIC, M., LEAKE, B., FROMM, M. F., WILKINSON, G. R. and KIM, R. B., 1999, OATP and p-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metabolism and Disposition, 27, 866-871.
-
(1999)
Drug Metabolism and Disposition
, vol.27
, pp. 866-871
-
-
Cvetkovic, M.1
Leake, B.2
Fromm, M.F.3
Wilkinson, G.R.4
Kim, R.B.5
-
6
-
-
0027275566
-
Physiological parameters in laboratory animals and humans
-
DAVIES, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 10, 1093-1095.
-
(1993)
Pharmaceutical Research
, vol.10
, pp. 1093-1095
-
-
Davies, B.1
Morris, T.2
-
7
-
-
0033178884
-
Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents
-
DOHERTY, A. M., 1999, Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Current Opinion in Chemical Biology, 3, 466-473.
-
(1999)
Current Opinion in Chemical Biology
, vol.3
, pp. 466-473
-
-
Doherty, A.M.1
-
8
-
-
0036139840
-
Update on the therapeutic potential of PDE4 inhibitors
-
DYKE, H. J. and MONTANA, J. G., 2002, Update on the therapeutic potential of PDE4 inhibitors. Expert Opinion on Investigational Drugs, 11, 1-13.
-
(2002)
Expert Opinion on Investigational Drugs
, vol.11
, pp. 1-13
-
-
Dyke, H.J.1
Montana, J.G.2
-
9
-
-
0032899660
-
Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation
-
ESSAYAN, D. M., 1999, Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochemical Pharmacology, 57, 965-973.
-
(1999)
Biochemical Pharmacology
, vol.57
, pp. 965-973
-
-
Essayan, D.M.1
-
10
-
-
0035193364
-
Cyclic nucleotide phosphodiesterases: Relating structure and function
-
FRANCIS, S. H., TURKO, I. V. and CORBIN, J. D., 2001, Cyclic nucleotide phosphodiesterases: relating structure and function. Progress in Nucleic Acid Research and Molecular Biology, 65, 1-52.
-
(2001)
Progress in Nucleic Acid Research and Molecular Biology
, vol.65
, pp. 1-52
-
-
Francis, S.H.1
Turko, I.V.2
Corbin, J.D.3
-
11
-
-
0025991541
-
Determination of the mechanism of demethylenation of (methylenedioxy) phenyl compounds by cytochrome P450 using deuterium isotope effects
-
FUKUTO, J. M., KUMAGAI, Y. and CHO, A. K., 1991, Determination of the mechanism of demethylenation of (methylenedioxy)phenyl compounds by cytochrome P450 using deuterium isotope effects. Journal of Medicinal Chemistry, 34, 2871-2876.
-
(1991)
Journal of Medicinal Chemistry
, vol.34
, pp. 2871-2876
-
-
Fukuto, J.M.1
Kumagai, Y.2
Cho, A.K.3
-
12
-
-
0142012148
-
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease
-
GAMBLE, E., GROOTENDORST, D. C., BRIGHTLING, C. E., TROY, S., QIU, Y., ZHU, J., PARKER, D., MATIN, D., MAJUMDAR, S., VIGNOLA, A. M., KROEGEL, C., MORELL, F., HANSEL, T. T., RENNARD, S. I., COMPTON, C., AMIT, O., TAT, T., EDELSON, J., PAVORD, I. D., RABE, K. F., BARNES, N. C. and JEFFERY, P. K., 2003, Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 168, 976-982.
-
(2003)
American Journal of Respiratory and Critical Care Medicine
, vol.168
, pp. 976-982
-
-
Gamble, E.1
Grootendorst, D.C.2
Brightling, C.E.3
Troy, S.4
Qiu, Y.5
Zhu, J.6
Parker, D.7
Matin, D.8
Majumdar, S.9
Vignola, A.M.10
Kroegel, C.11
Morell, F.12
Hansel, T.T.13
Rennard, S.I.14
Compton, C.15
Amit, O.16
Tat, T.17
Edelson, J.18
Pavord, I.D.19
Rabe, K.F.20
Barnes, N.C.21
Jeffery, P.K.22
more..
-
13
-
-
0034942625
-
Cilomilast: A second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease
-
GIEMBYCZ, M. A., 2001, Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease. Expert Opinion on Investigational Drugs, 10, 1361-1379.
-
(2001)
Expert Opinion on Investigational Drugs
, vol.10
, pp. 1361-1379
-
-
Giembycz, M.A.1
-
14
-
-
0035834052
-
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19
-
HA-DUONG, N. T., DIJOLS, S., MACHEREY, A. C., GOLDSTEIN, J. A., DANSETTE, P. M. and MANSUY, D., 2001, Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry, 40, 12112-12122.
-
(2001)
Biochemistry
, vol.40
, pp. 12112-12122
-
-
Ha-Duong, N.T.1
Dijols, S.2
Macherey, A.C.3
Goldstein, J.A.4
Dansette, P.M.5
Mansuy, D.6
-
15
-
-
0032201011
-
Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: A review
-
HEIENE, R. and MOE, L., 1998, Pharmacokinetic aspects of measurement of glomerular filtration rate in the dog: a review. Journal of Veterinary Internal Medicine, 12, 401-414.
-
(1998)
Journal of Veterinary Internal Medicine
, vol.12
, pp. 401-414
-
-
Heiene, R.1
Moe, L.2
-
16
-
-
0025121255
-
Metabolism of methylenedioxymethamphetamine: Formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct
-
HIRAMATSU, M., KUMAGAI, Y., UNGER, S. E. and CHO, A. K., 1990, Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. Journal of Pharmacology and Experimental Therapeutics, 254, 521-527.
-
(1990)
Journal of Pharmacology and Experimental Therapeutics
, vol.254
, pp. 521-527
-
-
Hiramatsu, M.1
Kumagai, Y.2
Unger, S.E.3
Cho, A.K.4
-
17
-
-
17644445622
-
Transporters and xenobiotic disposition
-
KIM, R. B., 2002, Transporters and xenobiotic disposition. Toxicology, 181-182, 291-297.
-
(2002)
Toxicology
, vol.181-182
, pp. 291-297
-
-
Kim, R.B.1
-
18
-
-
0028078626
-
Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: Inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid
-
LOPEZ-GARCIA, M. P., DANSETTE, P. M. and MANSUY, D., 1994, Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid. Biochemistry, 33, 166-175.
-
(1994)
Biochemistry
, vol.33
, pp. 166-175
-
-
Lopez-Garcia, M.P.1
Dansette, P.M.2
Mansuy, D.3
-
19
-
-
0029828960
-
Interspecies scaling: Predicting clearance of drugs in humans: Three different approaches
-
MAHMOOD, I. and BALIAN, J. D., 1996, Interspecies scaling: predicting clearance of drugs in humans: three different approaches. Xenobiotica, 26, 887-895.
-
(1996)
Xenobiotica
, vol.26
, pp. 887-895
-
-
Mahmood, I.1
Balian, J.D.2
-
20
-
-
0029146718
-
Diversity in cyclic nucleotide phosphodiesterase isoenzyme families
-
MANGANIELLO, V. C., MURATA, T., TAIRA, M., BELFRAGE, P. and DEGERMAN, E., 1995, Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Archives of Biochemistry and Biophysics, 322, 1-13.
-
(1995)
Archives of Biochemistry and Biophysics
, vol.322
, pp. 1-13
-
-
Manganiello, V.C.1
Murata, T.2
Taira, M.3
Belfrage, P.4
Degerman, E.5
-
21
-
-
8444233357
-
-
in preparation
-
MARFAT, A., HUNTER, K., CHENG, J. B., PILLAR, J. S., MAGEE, T. V., KUDLACZ, E. M., KALGUTKAR, A. S., TAYLOR, T. J. and WATSON, J. W., 2004 (in preparation).
-
(2004)
-
-
Marfat, A.1
Hunter, K.2
Cheng, J.B.3
Pillar, J.S.4
Magee, T.V.5
Kudlacz, E.M.6
Kalgutkar, A.S.7
Taylor, T.J.8
Watson, J.W.9
-
22
-
-
0000501191
-
PDE4 inhibitors - A review of the recent patent literature
-
MARTIN, T. J., 2001, PDE4 inhibitors - a review of the recent patent literature. Investigational drugs, 4, 312-338.
-
(2001)
Investigational Drugs
, vol.4
, pp. 312-338
-
-
Martin, T.J.1
-
23
-
-
0033831197
-
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation
-
MAYHEW, B. S., JONES, D. R. and HALL, S. D., 2000, An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. Drug Metabolism and Disposition, 28, 1031-1037.
-
(2000)
Drug Metabolism and Disposition
, vol.28
, pp. 1031-1037
-
-
Mayhew, B.S.1
Jones, D.R.2
Hall, S.D.3
-
24
-
-
0001074646
-
Subtypes of the type 4 cAMP phosphodiesterases: Structure, regulation and selective inhibition
-
MULLER, T., ENGELS, P. and FOZARD, J. R., 1996, Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends in Pharmacological Sciences, 17, 294-298.
-
(1996)
Trends in Pharmacological Sciences
, vol.17
, pp. 294-298
-
-
Muller, T.1
Engels, P.2
Fozard, J.R.3
-
25
-
-
0034232506
-
Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation
-
MURRAY, M., 2000, Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation. Current Drug Metabolism, 1, 67-84.
-
(2000)
Current Drug Metabolism
, vol.1
, pp. 67-84
-
-
Murray, M.1
-
26
-
-
0033863331
-
PDE4 inhibitors: Sustained patenting activity as leading drugs near the market
-
NORMAN, P., 2000, PDE4 inhibitors: sustained patenting activity as leading drugs near the market. Expert Opinion on Therapeutic Patents, 10, 1415-1427.
-
(2000)
Expert Opinion on Therapeutic Patents
, vol.10
, pp. 1415-1427
-
-
Norman, P.1
-
27
-
-
0033917295
-
Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, a herbal preparation used in the treatment of depression
-
OBACH, R. S., 2000, Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, a herbal preparation used in the treatment of depression. Journal of Pharmacology and Experimental Therapeutics, 294, 88-95.
-
(2000)
Journal of Pharmacology and Experimental Therapeutics
, vol.294
, pp. 88-95
-
-
Obach, R.S.1
-
28
-
-
0018668570
-
Effect of altered plasma protein binding on apparent volume of distribution
-
OIE, S. and TOZER, T. N., 1979, Effect of altered plasma protein binding on apparent volume of distribution. Journal of Pharmaceutical Sciences, 68, 1203-1205.
-
(1979)
Journal of Pharmaceutical Sciences
, vol.68
, pp. 1203-1205
-
-
Oie, S.1
Tozer, T.N.2
-
29
-
-
78651165715
-
The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature
-
OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370-2378.
-
(1964)
Journal of Biological Chemistry
, vol.239
, pp. 2370-2378
-
-
Omura, T.1
Sato, R.2
-
30
-
-
0032546575
-
Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: Detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate
-
RACHA, J. K., RETTIE, A. E. and KUNZE, K. L., 1998, Mechanism-based inactivation of human cytochrome P450 1A2 by furafylline: detection of a 1:1 adduct to protein and evidence for the formation of a novel imidazomethide intermediate. Biochemistry, 37, 7407-7419.
-
(1998)
Biochemistry
, vol.37
, pp. 7407-7419
-
-
Racha, J.K.1
Rettie, A.E.2
Kunze, K.L.3
-
31
-
-
0021162586
-
Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals
-
SAWADA, Y., HANANO, M., SUGIYAMA, Y. and IGA, T., 1984, Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. Journal of Pharmacokinetics Biopharmaceutical, 12, 241-261.
-
(1984)
Journal of Pharmacokinetics Biopharmaceutical
, vol.12
, pp. 241-261
-
-
Sawada, Y.1
Hanano, M.2
Sugiyama, Y.3
Iga, T.4
-
32
-
-
0037306174
-
Acyl glucuronide drug metabolites: Toxicological and analytical implications
-
SHIPKOVA, M., ARMSTRONG, V. W., OELLERICH, M. and WIELAND, E., 2003, Acyl glucuronide drug metabolites: toxicological and analytical implications. Therapeutic Drug Monitoring, 25, 1-16.
-
(2003)
Therapeutic Drug Monitoring
, vol.25
, pp. 1-16
-
-
Shipkova, M.1
Armstrong, V.W.2
Oellerich, M.3
Wieland, E.4
-
33
-
-
0034130633
-
Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
-
SOUNESS, J. E., ALDOUS, D. and SARGENT, C., 2000, Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology, 47, 127-162.
-
(2000)
Immunopharmacology
, vol.47
, pp. 127-162
-
-
Souness, J.E.1
Aldous, D.2
Sargent, C.3
-
34
-
-
0036179579
-
(+)-N-3-benzylnirvanol and (-)-N-3-benzyl-phenoparbital: New potent and selective in vitro inhibitors of CYP2C19
-
SUZUKI, H., KNELLER, B., HAINING, R. L., TRAGER, W. F. and RETTIE, A. E., 2002, (+)-N-3-benzylnirvanol and (-)-N-3-benzyl-phenoparbital: new potent and selective in vitro inhibitors of CYP2C19. Drug Metabolism and Disposition, 30, 235-239.
-
(2002)
Drug Metabolism and Disposition
, vol.30
, pp. 235-239
-
-
Suzuki, H.1
Kneller, B.2
Haining, R.L.3
Trager, W.F.4
Rettie, A.E.5
-
35
-
-
0018728344
-
Pseudoephedrine pharmacokinetics in the rat using a microanalysis technique
-
TILL, A. E. and BENET, L. Z., 1979, Pseudoephedrine pharmacokinetics in the rat using a microanalysis technique. Pharmacology, 18, 306-310.
-
(1979)
Pharmacology
, vol.18
, pp. 306-310
-
-
Till, A.E.1
Benet, L.Z.2
-
36
-
-
0037369493
-
Verification of the selectivity of (+)N-3-benzylnirvanol as a CYP2C19 inhibitor
-
WALSKY, R. L. and OBACH, R. S., 2003, Verification of the selectivity of (+)N-3-benzylnirvanol as a CYP2C19 inhibitor. Drug Metabolism and Disposition, 31, 343.
-
(2003)
Drug Metabolism and Disposition
, vol.31
, pp. 343
-
-
Walsky, R.L.1
Obach, R.S.2
-
37
-
-
0021720605
-
Results of a phase II study of the antidepressant effect of rolipram
-
ZELLER, E., STIEF, H. J., PFLUG, B. and SASTRE-Y-HERNANDEZ, M., 1984, Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry, 17, 188-190.
-
(1984)
Pharmacopsychiatry
, vol.17
, pp. 188-190
-
-
Zeller, E.1
Stief, H.J.2
Pflug, B.3
Sastre-Y-Hernandez, M.4
-
38
-
-
17944377504
-
An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers
-
ZUSSMAN, B. D., BENINCOSA, L. J., WEBBER, D. M., CLARK, D. J., COWLEY, H., KELLY, J., MURDOCH, R. D., UPWARD, J., WYLD, P., PORT, A. and FUDER, H., 2001a, An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers. Journal of Clinical Pharmacology, 41, 950-958.
-
(2001)
Journal of Clinical Pharmacology
, vol.41
, pp. 950-958
-
-
Zussman, B.D.1
Benincosa, L.J.2
Webber, D.M.3
Clark, D.J.4
Cowley, H.5
Kelly, J.6
Murdoch, R.D.7
Upward, J.8
Wyld, P.9
Port, A.10
Fuder, H.11
-
39
-
-
0034990671
-
Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilast
-
ZUSSMAN, B. D., DAVIE, C. C., KELLY, J., MURDOCH, R. D., CLARK, D. J., SCHOFIELD, J. P., WALLS, C., BIRRELL, C., WEBBER, D., QUINLAN, J., RITCHIE, S. Y. and CARR, A., 2001b, Bioavailability of the oral selective phosphodiesterase 4 inhibitor cilomilast. Pharmacotherapy, 21, 653-660.
-
(2001)
Pharmacotherapy
, vol.21
, pp. 653-660
-
-
Zussman, B.D.1
Davie, C.C.2
Kelly, J.3
Murdoch, R.D.4
Clark, D.J.5
Schofield, J.P.6
Walls, C.7
Birrell, C.8
Webber, D.9
Quinlan, J.10
Ritchie, S.Y.11
Carr, A.12
|